Abivax Sa ADR
(ABVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -297,067 | -114,410 | -55,172 | -190,712 | -87,916 |
| Depreciation Amortization | 930 | 595 | 288 | 1,190 | 620 |
| Accounts receivable | -2,690 | 2,596 | -2,277 | N/A | 4,332 |
| Accounts payable and accrued liabilities | -16,669 | 15,595 | 13,436 | N/A | -18,608 |
| Other Working Capital | 15,647 | 17,551 | 9,493 | 3,072 | -14,048 |
| Other Operating Activity | 138,655 | 2,448 | -827 | 19,729 | 23,894 |
| Operating Cash Flow | $-161,193 | $-75,625 | $-35,058 | $-166,721 | $-91,725 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -64 | -72 | -46 | -693 | -254 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -3 |
| Other Investing Activity | 5,382 | 1,512 | 1,186 | 17,749 | 14,747 |
| Investing Cash Flow | $5,317 | $1,441 | $1,140 | $17,056 | $14,493 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 52,277 |
| Debt Repayment | -2,558 | -2,484 | -2,305 | N/A | -4,711 |
| Common Stock Issued | 760,710 | N/A | N/A | N/A | 263 |
| Other Financing Activity | -72,175 | -16,365 | -5,951 | 30,523 | -4,406 |
| Financing Cash Flow | $685,977 | $-18,849 | $-8,256 | $30,523 | $43,423 |
| Exchange Rate Effect | -10,450 | -2,026 | -738 | 2,578 | 1,906 |
| Beginning Cash Position | 168,580 | 163,720 | 151,937 | 272,626 | 271,316 |
| End Cash Position | 689,304 | 69,186 | 109,117 | 156,062 | 239,413 |
| Net Cash Flow | $520,723 | $-94,534 | $-42,820 | $-116,565 | $-31,903 |
| Free Cash Flow | |||||
| Operating Cash Flow | -161,193 | -75,625 | -35,058 | -166,721 | -91,725 |
| Capital Expenditure | -64 | -72 | -46 | N/A | -254 |
| Free Cash Flow | -161,257 | -75,696 | -35,105 | -166,721 | -91,979 |